is a national web registry of federally and privately supported research studies conducted in the US and around the world. DOCR is the system administrator for for Duke.

This page provides information about registering and maintaining your trial in

If you have questions, contact the DOCR team.

When Does a Study Need to Be Registered?

Per Duke Policy, studies that meet the following criteria must be registered prior to receiving institutional approval:

  • Duke Investigator-initiated Applicable Clinical Trials
  • Duke Investigator-initiated studies that meet FDAMA criteria
  • NIH-funded interventional clinical trials (when Duke is the primary grant awardee)
  • Qualifying trials billing insurance (externally sponsored and Duke Investigator-initiated)

All other studies should be registered prior to enrolling subjects.

If you are unsure of whether or not your study must be registered in, please contact the DOCR team for assistance.

When is Registration Required? was mandated by the Food and Drug Administration Modernization Act of 1997 (FDAMA) and expanded under the Food and Drug Administration Amendments Act of 2007 (FDAAA).  Final regulations will be effective as of January 18, 2017.  All “Applicable Clinical Trials” are required to be registered and have results entered on  For complete statutory definitions and more information about the meaning of "applicable clinical trial," see Elaboration of Definitions of Responsible Party and Applicable Clinical Trial (PDF).

Non-compliance with registration and results reporting may result in fines up to $10,000 per day. Per Duke Policy, Applicable Clinical Trials will not receive institutional approval until the study has been registered on

Device Applicable Clinical Trial (ACT) Drug Applicable Clinical Trial (ACT)
A study is an applicable device clinical trial if it meets four criteria:
  1. prospective clinical study of health outcomes;
  2. comparing an intervention with a device product against a control (all clinical trials with one or more arms and pre-specified outcome measure(s) are considered controlled);
  3. subject to section 510(k), 515, or 520(m) of the Federal Food, Drug, and Cosmetic Act (FDC Act); and
  4. other than a small clinical trial to determine the feasibility of a device, or a clinical trial to test prototype devices where the primary outcome measure relates to feasibility and not to health outcomes.

A study is an applicable drug clinical trial if it meets four criteria:

  1. controlled (all clinical trials with one or more arms and pre-specified outcome measure(s) are considered controlled);
  2. clinical investigation;
  3. other than a Phase I study*;
  4. subject to section 505 of the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act.

*Phase I studies for life-threatening illnesses that are conducted under an IND and testing effectiveness must be registered but are not ACTs. Language in the Consent Form

By federal regulation, ACTs must include the following language in the consent form.  The language cannot be altered in any way.

"A description of this clinical trial will be available on, as required by US law.  This website will not include information that can identify you.  At most, the website will include a summary of the results.  You can search this website at any time."

Effective January 18, 2017, all NIH-funded interventional clinical trials must be registered and have results submitted in All interventional trials are included in this policy, even those that are not considered to be Applicable Clinical Trials (ACTs), such as behavioral, surgery, phase 1 drug, and feasibility device studies. This policy applies to studies that are funded in part or whole by the NIH, and are submitted on or after the effective date. Registration of NIH-funded studies must be completed before full institutional approval can be received. Results, including adverse events, must be submitted within one year from the date the last patient was evaluated for the primary outcome measure.

NIH definition of clinical trial – one or more human subjects is prospectively assigned to one or more interventions that evaluate the effects of those interventions on health related biomedical or behavioral outcomes.

For further information on the NIH definition of clinical trial, see

Registration in is required for all “Qualifying Trials”, meaning clinical trials that are qualified for coverage as specified in the "Medicare National Coverage Determination (NCD) Manual," Section 310.1. The National Clinical Trial (NCT) Number that is assigned by must be included on all hospital and professional claims for related items/services.  Per Duke Policy, all qualifying trials that are billing to insurance must be registered before the study can receive institutional approval in eIRB.

The International Committee of Medical Journal Editors (ICMJE) requires that all clinical trials be entered into a public registry as a condition of consideration for publication. 

ICMJE defines a clinical trial as “any research that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and–effect relationship between a medical intervention and a heath outcome.”  Medical interventions include drugs, procedures, devices, behavioral treatments, dietary interventions and process-of-care changes.  

Many journals follow ICMJE guidelines.

For each clinical trial supported by a federal department or agency, one IRB-approved consent form must be uploaded to a publicly available federal website after enrollment has closed. To facilitate compliance with this requirement, any federally-supported clinical trial with initial IRB approval on or after January 21, 2019 will need to be registered on before receiving full institutional approval in OnCore. After enrollment has closed, one IRB-approved consent form will need to be posted in the record. This consent form can be posted by the study team in at the same time they are making status updates and editing completion dates. Please contact for questions or assistance. Training

Course Name and Description Link

Intro to Regulation and Policy Overview: This module will provide an introduction to and cover why it is important to register and report results, who is responsible, when to register, and the Duke process. 

Register Registering Trials and Maintaining Records: This module will walk you through who can register trials in, what information is included in a registration, resources to help with registration, and what is required for record maintenance once a trial is registered.  Register Results Submission Overview: This module will cover which studies must submit results, what information is required for results submission, when to submit results, and Duke's process for results submission. Register Microlearning Videos

This WarpWire library houses several short videos to help clinical research staff with specific functions in Any videos created for training purposes will be added to this library.

How to Request a Account

Email the DOCR team to request a new account. Within 2 business days you will receive an email from DOCR containing your login name and another email from with your temporary password.  As soon as possible log on to the Protocol Registration and Results System to reset your password. The Organization name is DukeUMC.  From the Accounts drop down menu, select "Change Password".